Most Recent
Fresh off the back of a $212.5 million settlement in three class actions over the Defence Department's use of fire-fighting foam, Shine Laywers has launched another class action over the toxic chemical on behalf of 40,000 residents across Australia.
Two gynaecologists have lost their bid to dismiss a negligence lawsuit brought by a patient implanted with a Johnson & Johnson pelvic mesh device found by a judge overseeing a related class action to have been defective.
Johnson & Johnson has appealed a ruling awarding the three lead applicants in a class action over its pelvic mesh products a combined $2.6 million in damages, after a judge found the company failed to adequately warn women of the implants' risks.
The makers or popular opioid drugs like OxyContin and Fentanyl may face a class action in Australia by consumers who allege they suffered financial loss from the addictive drugs.
The judge overseeing the $212.5 million settlement in three toxic foam class actions against the Commonwealth of Australia has been told of at least one objection to the deal and has flagged difficulties taking submissions from opposing group members at an upcoming approval hearing.
The Federal Government will pay $212.5 million to settle three class actions over the use of allegedly toxic firefighting foam at government military bases.
A judge has ordered Johnson & Johnson to include a graphic warning on the patient information leaflets and instructions for use that accompany four of its pelvic mesh products, following a class action over the devices which saw the three lead applicants awarded $2.6 million in damages.
A Federal Court judge has awarded combined damages of $2.6 million to the lead applicants in the Johnson & Johnson pelvic mesh class action, following a landmark ruling in November which found that the pharmaceutical giant did not adequately warn of the risks of the implants.
The Federal Court judge overseeing three class actions against the Commonwealth of Australia over allegedly toxic firefighting foam has questioned the terms of the in-principle settlement reached last week, including whether the settlement amount should remain confidential.
Medtronic owned Covidien and two other medical device manufacturers have been hit with a class action on behalf of thousands of women who claim to have suffered lifelong complications from the devices, the third class action over pelvic mesh implants brought in Australia.